Chapman Rowan E
Natera, Inc. · Director
Chapman Rowan E serves as a Director at Natera, Inc., a company focused on genetic testing and diagnostics in the healthcare sector. His recent insider trading activity, tracked through SEC Form 4 filings, highlights a series of sales from December 9, 2025, to June 30, 2026. Notably, he executed three sales, with the largest transaction valued at approximately $972.3K, reflecting a strategic approach to managing his holdings in Natera, Inc. (NTRA).
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $972k4k shares | SellDec 5, 2025 | $243.08 | $265.25 | |
| $89k366 shares | SellDec 5, 2025 | $243.39 | $265.25 |